甲状腺相关眼病的药物治疗研究进展  

Drug therapy for thyroid associated ophthalmopathy

作　　者：陈秀珠 张凯 韦岩笑 丛晨阳[1] Chen Xiuzhu;Zhang Kai;Wei Yanxiao;Cong Chenyang(Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine,Jinan,250002,China)

机构地区：[1]山东中医药大学附属眼科医院眼科,济南250002

出　　处：《国际医药卫生导报》2025年第6期927-929,共3页International Medicine and Health Guidance News

基　　金：山东省医药卫生科技项目(202307021606)。

摘　　要：甲状腺相关眼病多见于甲亢患者,但也会发生在甲状腺功能正常、亚临床或显性甲减患者中,是一种与甲状腺有关的器官自身免疫疾病。目前,甲状腺相关眼病治疗多以药物治疗为主,但在药物治疗中常会出现相关不良反应。本文对甲状腺相关眼病的药物治疗进行综述,为甲状腺相关眼病患者治疗及护理提供参考。Thyroid-associated ophthalmopathy is a thyroid-related organautoimmune disease.It mainly occurs in patients with hyperthyroidsm,but may occur in patients with euthyroidism and subclinical or overt hypothyroidism.The current treatment is mainly drug therapy,but there are often adverse reactions in the application of drug therapy.This article reviews the thyroid related ophthalmic drugs,so as to provide references for the patients'treatment and nursing care.

关 键 词：甲状腺相关眼病 自身免疫疾病 药物治疗 进展 

分 类 号：R58[医药卫生—内分泌]